Rishi Reddy is a Managing Director and leads the firm’s venture and growth equity strategy. As a former founder, he has an innate passion for working with entrepreneurs throughout the life cycle of a business. He focuses on partnering with durable transformative companies across the healthtech and fintech ecosystems.

Prior to Tarsadia, Rishi was the founder and CEO of DigiPath Solutions, an early innovator in the digital anatomic pathology space. After exiting DigiPath, Rishi joined Tarsadia where he helped build the venture and growth practice. Rishi has led the firm’s investments in CUE Health, PhilRx, Fathom, Chronus Health, AvantStay, Petal, YieldStreet, BoltTech, TrueMotion, Nvoicepay and BrightVine. He currently serves on the boards of AvantStay, PhilRx, Chronus Health, Fathom and Envisics, as a board observer on BoltTech, YieldStreet and Petal and formerly as a board observer on CUE Health (Nasdaq:HLTH).

Rishi graduated summa cum laude from Babson College with a B.S. in management and the Wharton School with an M.B.A.